Modafinil is a treatment approved for narcolepsy and shift-work disorder. It is a stimulant similar to Adderall and Ritalin.
Studies show that modafinil can potentially reduce ADHD symptoms in children and teenagers.
Currently, modafinil is not approved as a treatment for ADHD in adults or children, though it is approved and available as a drug. Some physicians may prescribe it as an off-label treatment for ADHD.
In a meeting regarding approval of modafinil as an ADHD treatment, FDA decided against approval partly due to their concerns regarding a rare skin side effect.
The FDA meeting that recommended the rejection of modafinil as an ADHD treatment did agree that modafinil may be an effective treatment for ADHD in children and teenagers:
Randomized trials on modafinil and ADHD have shown that it can reduce ADHD symptoms. For example, one study below found that modafinil reduces ADHD symptoms while improving overall health and well-being:
Another study found that modafinil may be nearly as effective as Ritalin in reducing ADHD symptoms:
Studies on modafinil have shown evidence that it can reduce ADHD symptoms, similar to Adderall or Ritalin. However, due to rare but severe side effects, it is not currently approved as an ADHD treatment.
Approval of any medication or indication requires a balance of effectiveness and safety. While modafinil may be effective in reducing ADHD symptoms, there's not enough evidence showing that the risks of modafinil outweigh its benefits.